Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer

SIMPLE SUMMARY: Malignant tumors, especially pancreatic cancer, are the major contributors to cancer mortality worldwide, and their effective treatments are still limited. Our study suggested that NRPs, especially NRP1, are attractive diagnostic and prognostic biomarkers, mediate immunoregulation, a...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Li-Hong, Zhang, Xiao-Zhen, Lao, Meng-Yi, Zhang, Han-Jia, Yang, Han-Shen, Bai, Xue-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136637/
https://www.ncbi.nlm.nih.gov/pubmed/37190154
http://dx.doi.org/10.3390/cancers15082225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136637/
https://www.ncbi.nlm.nih.gov/pubmed/37190154
http://dx.doi.org/10.3390/cancers15082225

Ejemplares similares